Current through Vol. 42, No. 7, December 16, 2024
Section 310:281-11-7 - Additional operational controls for fluoroscopic x- ray systems and spot-film devices(a) Fluoroscopic configuration, including fluoroscopic table designs when combined with operating and safety procedures, shall not permit any portion of any individual's body, except the head, neck, and extremities, to be exposed to scattered radiation emanating from above or below the tabletop unless the radiation has passed through not less than a total of 0.25 millimeter lead equivalent material. The material may be, but is not limited to, drapes, self-supporting curtains, or viewing shields, in addition to any lead equivalency provided by a protective apron.(b) Where sterile fields or special procedures prohibit the use of normal protective barriers or drapes, 310:281-11-7(a) does not apply, if all of the following conditions are met: (1) All persons, except the patient, in the room where fluoroscopy is performed, shall wear protective aprons which provide a shielding equivalent of 0.5 millimeter of lead.(2) The fluoroscopist and all other personnel in the room, except the patient, shall have appropriate personnel monitoring devices.(3) The fluoroscopic field size shall be reduced to the absolute minimum required for the procedure being performed (area of clinical interest).(4) Operating and safety procedures shall reflect the above conditions, and fluoroscopy personnel shall exhibit awareness of situations requiring the use and/or nonuse of the protective drapes. (c) For image-intensified fluoroscopic systems with only a manual mode of collimation, the x-ray field produced shall be limited to the area of the spot-film cassette at 16 inches above tabletop. Additionally, during fluoroscopy, the beam shall be restricted to the area of the input phosphor.Okla. Admin. Code § 310:281-11-7
Added at 8 Ok Reg 3503, eff 8-15-91 (emergency); Added at 9 Ok Reg 1643, eff 5-29-92; Amended at 21 Ok Reg 1037, eff 5-13-04Amended by Oklahoma Register, Volume 38, Issue 24, September 1, 2021, eff. 9/11/2021